The execs at Haleon, a huge multinational consumer products company, ought to take a good look in the mirror. That is, unless misleading, sleazy marketing is in their mission statement. In that case, ...

Bernstein analyst Courtney Breen maintained a Hold rating on Pfizer (PFE – Research Report) yesterday and set a price target of $32.00. The company’s shares closed yesterday at $26.91.

Group alleged bias toward white, Asian-American applicants Pfizer expresses pride in its commitment to diversity Jan 31 (Reuters) - Pfizer (PFE.N), opens new tab has resolved a lawsuit by a ...

Analyst Tim Anderson from Bank of America Securities reiterated a Hold rating on Pfizer (PFE – Research Report) and keeping the price target at $29.00. Tim Anderson has given his Hold rating due ...

OpenAI reveals a sleek rebrand featuring a refined logo, custom typeface, and cohesive design, blending human creativity with ...

Few companies embody the term 'pharma giant' as much as Pfizer. Here we take a look at the colourful history of one of the biggest drugmakers in the world. Pfizer was founded in 1849 by two recent ...

OpenAI has finally unveiled its first major rebrand, with a similar but new logo, a new typeface, and colour palette. This ...

Pfizer Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services, Scrap for the year ending 31-Mar-2024.For the quarter ended 31-12-2024, the company has reported a Standalone Total ...

Influenza causes 140,000 to 710,000 hospitalisations and 12,000 to 52,000 deaths in the US every year, as well as economic losses of around $25 billion a year, according to Pfizer.

After hours: 31 January at 7:59:49 pm GMT-5 ...

The biggest stories of the day delivered to your inbox.